Johns Hopkins engineers have created a new optical tool that could improve cancer imaging. Their approach, called SPECTRA, uses tiny nanoprobes that light up when they attach to aggressive cancer ...

Two major advances in MRI technique have been shown to produce data that enables differentiation between metastatic and primary tumours: magnetic resonance spectroscopy (MRS) and perfusion ...

MR spectroscopy compared with DW-MRI and DCE-MRI at 3-tesla for the noninvasive prediction of short-term radiation response for patients with localized ... A randomized phase II study of OGX-427 plus ...

Concordance of FDG-PET scan and MRI- spectroscopy in primary and metastatic intracranial tumors. JCO 22 , 1551-1551 (2004). DOI: 10.1200/jco.2004.22.90140.1551 ...

May 7, 2003 — Magnetic resonance imaging (MRI) was better than scintigraphy or positron emission tomography (PET) for whole body detection of skeletal metastases, according to the results of a ...

Imaging bone metastases from prostate cancer presents several challenges. The lesions are usually sclerotic and appear late on the conventional X-ray. Bone scintigraphy is the mainstay of lesion ...

October 3, 2007 — Researchers say their work is adding weight to the argument that magnetic resonance spectroscopy should be added to routine breast magnetic resonance imaging (MRI) exams. "This ...

The new tool— combining Raman spectroscopy and machine learning—introduces the Ramanome-based Metastasis Index (RMI), offering an innovative means of diagnosing and managing cancer.

Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida, discusses a ...

Raman spectroscopy is already used in neurosurgery, but in a more invasive and less precise manner. "Studies have been conducted on its use during brain tumor surgery in patients," Valiente notes.

The team found that, unlike CT or MRI scans that can indicate the presence of a tumor but not the specific molecular signatures that can alert physicians to current or impending metastasis, SPECTRA ...